Celiac disease (CD) is an intestinal inflammatory condition that develops in genetically susceptible individuals after exposure to dietary wheat gliadin. The role of post-translational modifications of gliadin catalyzed by tissue transglutaminase (tTG) seems to play a crucial role in CD. However, it remains to be established how and where tTG is activated in vivo. We have investigated whether gliadin peptides modulate intracellular Ca(2+) homeostasis and tTG activity. METHODS/PRINCIPAL FINDINGS: We studied Ca(2+) homeostasis in Caco-2 cells by single cell microfluorimetry. Under our conditions, A-gliadin peptides 31-43 and 57-68 rapidly mobilized Ca(2+) from intracellular stores. Specifically, peptide 31-43 mobilized Ca(2+) from the endopla...
BACKGROUND: An unresolved question in coeliac disease is to understand how some toxic gliadin pept...
Type 2 transglutaminase (TG2) is a ubiquitous enzyme able to modify gliadin peptides introduced into...
K562(S) agglutination has been used as a rapid and economic tool for the in vitro screening of the t...
Celiac disease (CD) is an intestinal inflammatory condition that develops in genetically susceptible...
Background: Celiac disease (CD) is an intestinal inflammatory condition that develops in genetically...
Type 2 transglutaminase (TG2) is a ubiquitous enzyme able to modify gliadin peptides introduced into...
An unresolved question in coeliac disease is to understand how some toxic gliadin peptides, in parti...
Anti-tissue transglutaminase (tTG) antibodies are specifically produced in the small-intestinal muco...
Celiac disease (CD) is a frequent inflammatory intestinal disease, with a genetic background, caused...
Anti-tissue transglutaminase (tTG) antibodies are specifically produced in the small-intestinal muco...
Enzymatic modification of gliadin peptides by human transglutaminase 2 (TG2) is a central step in ce...
Celiac disease (CD) is a complex inflammatory and auto-immune disorder triggered by the ingestion of...
BACKGROUND: An unresolved question in coeliac disease is to understand how some toxic gliadin pept...
Type 2 transglutaminase (TG2) is a ubiquitous enzyme able to modify gliadin peptides introduced into...
K562(S) agglutination has been used as a rapid and economic tool for the in vitro screening of the t...
Celiac disease (CD) is an intestinal inflammatory condition that develops in genetically susceptible...
Background: Celiac disease (CD) is an intestinal inflammatory condition that develops in genetically...
Type 2 transglutaminase (TG2) is a ubiquitous enzyme able to modify gliadin peptides introduced into...
An unresolved question in coeliac disease is to understand how some toxic gliadin peptides, in parti...
Anti-tissue transglutaminase (tTG) antibodies are specifically produced in the small-intestinal muco...
Celiac disease (CD) is a frequent inflammatory intestinal disease, with a genetic background, caused...
Anti-tissue transglutaminase (tTG) antibodies are specifically produced in the small-intestinal muco...
Enzymatic modification of gliadin peptides by human transglutaminase 2 (TG2) is a central step in ce...
Celiac disease (CD) is a complex inflammatory and auto-immune disorder triggered by the ingestion of...
BACKGROUND: An unresolved question in coeliac disease is to understand how some toxic gliadin pept...
Type 2 transglutaminase (TG2) is a ubiquitous enzyme able to modify gliadin peptides introduced into...
K562(S) agglutination has been used as a rapid and economic tool for the in vitro screening of the t...